High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed...
The first contract the European Commission has negotiated on behalf of the EU member states with a pharmaceutical company entered into force following the formal signature...
New coronavirus vaccines could be available from the end of 2020 or the beginning of 2021, a presentation by French Health Minister Olivier Veran suggested on...
Trial data for the University of Oxford and AstraZeneca’s possible coronavirus vaccine could be given to regulators this year but corners cannot be cut to speed...
The European Commission has concluded exploratory talks with Moderna to purchase a potential vaccine against COVID-19. Moderna is the fifth company with which the Commission has...
Welcome, everyone, to the last European Alliance for Personalised Medicine (EAPM) update of the week – we hope you are enjoying your holidays. August is getting...
The European Commission has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19. This is following the positive steps with Sanofi-GSK on 31 July...